Versant Capital Management’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-52
| Closed | – | – | 1866 |
|
|
2018
Q4 | $0 | Hold |
52
| – | – | ﹤0.01% | 1783 |
|
|
2018
Q3 | $0 | Hold |
52
| – | – | ﹤0.01% | 1755 |
|
|
2018
Q2 | $0 | Hold |
52
| – | – | ﹤0.01% | 1754 |
|
|
2018
Q1 | $0 | Hold |
52
| – | – | ﹤0.01% | 1783 |
|
|
2017
Q4 | $0 | Hold |
52
| – | – | ﹤0.01% | 1736 |
|
|
2017
Q3 | $0 | Hold |
52
| – | – | ﹤0.01% | 1676 |
|
|
2017
Q2 | $0 | Hold |
52
| – | – | ﹤0.01% | 1634 |
|
|
2017
Q1 | $0 | Hold |
52
| – | – | ﹤0.01% | 1635 |
|
|
2016
Q4 | $0 | Hold |
52
| – | – | ﹤0.01% | 1634 |
|
|
2016
Q3 | $0 | Hold |
52
| – | – | ﹤0.01% | 1586 |
|
|
2016
Q2 | $0 | Hold |
52
| – | – | ﹤0.01% | 1532 |
|
|
2016
Q1 | $0 | Hold |
52
| – | – | ﹤0.01% | 1557 |
|
|
2015
Q4 | $0 | Buy |
+52
| New | – | ﹤0.01% | 1500 |
|